GET THE APP

..

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Madoka Takeuchi


Japan

Publications
  • Review Article
    Application of Longitudinal Analysis for Regulatory Science
    Author(s): Madoka Takeuchi and Masahiro TakeuchiMadoka Takeuchi and Masahiro Takeuchi

    The standard primary analysis in a clinical trial is the change from baseline analysis, failing to use all information and multiple measurements collected for each individual at various timepoints. Change from baseline analysis fails to observe the trend of the outcome, however, most decision-making in regulatory science is based on the single p-value from the change from baseline analysis. There are many possible longitudinal analysis models, utilizing repeated measurements, with the random effects model, otherwise known as the Laird-Ware model, being the most powerful and efficient model under certain assumptions. A semi-parametric approach is the Generalized Estimating Equation2. Although the longitudinal models may result in more.. Read More»
    DOI: 10.4172/2167-7689.1000127

    Abstract PDF

Relevant Topics

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward